To assess the immune-related adverse events of Renal Cell Carcinoma patients treated with nivolumab and effect of numbers of previous treatment lines
Latest Information Update: 28 Apr 2021
At a glance
- Drugs Nivolumab (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions; Therapeutic Use
- 28 Apr 2021 New trial record
- 02 Apr 2021 Results published in the Medicine